About Avirmax
Avirmax is a Healthcare company based in Hayward (United States) founded in 2019 by Shengjiang Shawn Liu. RAAV-mediated gene therapies for diseases are developed by Avirmax. Its chief executive, as recorded, is Shengjiang Shawn Liu. Avirmax offers products and services including Genetic Medicines and Bioprocess Development Services. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is Avirmax Inc. Similar companies include Senti Biosciences, Tenaya Therapeutics and Mineralys Therapeutics; 3 of its 3 listed similar companies have raised funding.
Company details
Developer of rAAV mediated gene therapies. The lead candidate AVMX- 801 for COVID, other candidates AVMX-810 for cardiovascular disease, AVMX-901 for genetic disease, and others. These therapies are based on BAC-to-AAV technology and enhanced gene expression technology.
- Headquarters Hayward, United States
- Founders Shengjiang Shawn Liu
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website avirmax.com
- Social LinkedIn X
- Legal Name Avirmax Inc.
Products & Services of Avirmax
Avirmax offers a comprehensive portfolio of products and services, including Genetic Medicines and Bioprocess Development Services.
Develops treatments for chronic and degenerated ocular diseases.
Offers technology transfer for AAV-based genetic medicine production.
People of Avirmax
5 people are tracked at Avirmax (2 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Shengjiang Shawn Liu | Co-Founder & CEO & President | Leadership |
June Song | Director Of Operations | Leadership |
Stephen Garger | Board Member | Board & advisors |
Nancy Chang | Board Member | Board & advisors |
Jan Rosing | Board Member | Board & advisors |
Complete people profiles for Avirmax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Avirmax
Avirmax has 3 listed similar companies in our database, 3 of them funded. They include Senti Biosciences, Tenaya Therapeutics and Mineralys Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentibio.com | 2016 | San Francisco, United States | $158M | Cell-based therapies for cancer treatment are developed. | ||
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| mineralystx.com | 2020 | Radnor, United States | $158M | 28 | Hypertension therapies via aldosterone synthase inhibition are developed. |
Detailed similar companies of Avirmax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avirmax
Websites that share an audience with Avirmax (avirmax.com).
Websites whose visitors overlap most with Avirmax. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sundeepinc.com | sundeepinc.com | 100% | #10,000,011 | – | |
| productionrobotics.com | 100% | View details | |||
xrtlogistics.com | xrtlogistics.com | 99% | #2,279,294 | – | |
lingosa.com | lingosa.com | 99% | – | ||
pacificdiecut.com | pacificdiecut.com | 99% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Avirmax
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Avirmax (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avirmax
Complete news archive for Avirmax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avirmax
Avirmax was founded in 2019.
Avirmax is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Shengjiang Shawn Liu is the CEO of Avirmax, as recorded in our data. They have also founded this company.
Developer of rAAV mediated gene therapies. The lead candidate AVMX- 801 for COVID, other candidates AVMX-810 for cardiovascular disease, AVMX-901 for genetic disease, and others. These therapies are based on BAC-to-AAV technology and enhanced gene expression technology.
Avirmax's top competitors include Senti Biosciences, Tenaya Therapeutics and Mineralys Therapeutics.
Avirmax offers Genetic Medicines and Bioprocess Development Services.
Avirmax operates through Avirmax Inc..